GCGregorio Catalán-Uribarrena

Gregorio Catalán-Uribarrena

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Gregorio Catalán-Uribarrena has a total of 124 co-authors. Here are the top co-authors by number of shared publications:

  • Iñigo Pomposo

    Cruces Hospital

    3 shared publications
  • Eva González Diaz

    Department of Interventional Neuroradiology, Hospital Universitario De Cruces, Barakaldo, País Vasco, Spain

    2 shared publications
  • F. Iturri Clavero

    Servicio de Anestesiología, Reanimación y Terapéutica del Dolor, Hospital universitario Cruces, Barakaldo, Bizkaia, Spain; Sección de Neurociencias, Sociedad de Anestesiología y Reanimación, Spain

    2 shared publications
  • I. Ingelmo Ingelmo

    Sección de Neurociencias, Sociedad de Anestesiología y Reanimación, Spain; Servicio de Anestesiología y Reanimación, Hospital Universitario Ramón y Cajal, Madrid, Spain

    2 shared publications
  • M.P. Valcarcel Fernández

    Servicio de Anestesiología, Reanimación, Medicina Perioperatoria y del Dolor, Hospital Universitario Mutua Terrassa, Terrassa, Barcelona, Spain; Sección de Neurociencias, Sociedad de Anestesiología y Reanimación, Spain

    2 shared publications
  • A. Carrasco

    Cruces Hospital

    1 shared publication

Latest Publications

  • Neuroanesthesiological management of carotid rupture in the endoscopic endonasal approach to the skull base

    by F. Iturri Clavero, I. Ingelmo Ingelmo, K. de Orte Sancho, M.P. Valcarcel Fernández, G. Catalán Uribarrena, F. Valcarcel Martín, O. Prieto Calderón, E.M. González Díaz, A. Uresandi Iruin

  • Manejo neuroanestesiológico de la rotura carotídea en el abordaje endoscópico endonasal a la base del cráneo

    by F. Iturri Clavero, I. Ingelmo Ingelmo, K. de Orte Sancho, M.P. Valcarcel Fernández, G. Catalán Uribarrena, F. Valcarcel Martín, O. Prieto Calderón, E.M. González Díaz, A. Uresandi Iruin

  • Combined Predictive Model for Endoscopic Third Ventriculostomy Success in Adults and Children

    by Iñigo L. Sistiaga, Gregorio Catalán-Uribarrena, Silvia Pérez-Fernández, Alejandro Carrasco, Jone Iglesias, Edurne Ruiz de Gopegui, Iñigo Pomposo


  • Agreement in the assessment of metastatic spine disease using scoring systems

    by Estanislao Arana, Francisco M. Kovacs, Ana Royuela, Beatriz Asenjo, Ursula Pérez-Ramírez, Javier Zamora, Víctor Abraira, Lucía Alcázar, Ana Alonso, Luis Álvarez, et al.


  • Prognostic factors and survival in a prospective cohort of patients with high-grade glioma treated with carmustine wafers or temozolomide on an intention-to-treat basis

    by Gregorio Catalán-Uribarrena, Gaizka Bilbao-Barandica, Iñigo Pomposo-Gaztelu, José Undabeitia-Huertas, Edurne Ruiz de Gopegui-Ruiz, Lara Galbarriatu-Gutiérrez, Manuel Canales-Llantada, Jon Aurrecoechea-Obieta, Alfonso Igartua-Azkune, Guillermo Carbayo-Lozano

    Patients with high-grade glioma can be treated with carmustine wafers or following the Stupp protocol. As far as we are aware, no scientific evidence has been published comparing the two treatments. The primary objective of this study was to analyse the survival of groups of patients with each of these treatment modalities. The secondary objective was to assess the influence of the usual prognostic factors on the patients in our hospital. A prospective cohort of 110 patients with single, supratentorial high-grade glioma treated by craniotomy and tumour resection was retrospectively studied. Half of the patients had carmustine wafers placed during this operation while the others (55) did not, the latter group receiving first-line systemic chemotherapy on an intention-to-treat basis. Patients treated with carmustine wafers had a median survival of 13.414 months compared with 11.047 in the group without implants (p = 0.856). For the overall cohort of patients, the following factors were found to influence survival: age (p < 0.0001), postoperative KPS score (p = 0.001), histological grade (p = 0.004), RPA class (p = 0.001), extent of resection (p = 0.002) and salvage surgery (p = 0.028). In this prospective cohort of patients, analysed on the basis of intention-to-treat at the time of the first surgery, no statistically significant differences in survival were found between the two treatment modalities (carmustine wafers vs. first-line systemic chemotherapy). On the other hand, age, preoperative KPS, histological grade, and RPA class were confirmed to be prognostic factors in this cohort. Finally, the extent of resection was also found to influence survival.


  • Surgical results and complications in a series of 71 consecutive cervical spondylotic corpectomies

    by Gaizka Bilbao, Melchor Duart, Juan Jose Aurrecoechea, Iñigo Pomposo, Alfonso Igartua, Gregorio Catalán, Maria Luisa Jauregui, Jesus Garibi

    Cervical corpectomy is a common procedure in spondylosis. It is normally a well-tolerated surgery and clinical improvement is widely described. However, it is associated with potential risky complications (subsidence, clinical deterioration, vertebral artery injury...); thus, a judicious surgical indication and a good technique are required. We revised retrospectively the clinical evolution and complications of 71 spondylotic corpectomies in a series of 100 consecutive patients operated on due to different ethiological causes from January 2001 to September 2007 at our hospital. Among the 71 cases, a single-level corpectomy was performed in 46 cases and a two level in 25. The graft we used was a titanium mesh filled with bone from the removed vertebra in 69 cases and a telescopic cage in two additional cases. We stabilized the construction with a locking plate. The presurgical clinical status of patients, according to the Nurick grading scale was as follows: 30 patients were grade 0, 12 were grade 1, eight were grade 2, 14 were grade 3, five were grade 4 and two were grade 5. After decompression, 41 patients were considered cured, three were grade 1, seven were grade 2, 11 were grade 3, seven were grade 4 and one was grade 5. One patient died in the postoperative period. Globally, 44 (62%) patients achieved good or excellent results (grades 0–1), 15 (21%) remained as previously (grade >1), six (8%) improved partially and five (7%) worsened. Forty (95%) grades 0 and 1 patients became cured, and four (50%), four (31%) and two (28%) grades 2, 3 and 4–5, respectively, experienced a postsurgical improvement. Significant complications occurred in 18 (25%) patients. The most significant were: hardware failure (n = 7), subsidence in five cases (one required intervention) and incorrect screw placement in two (one required intervention); permanent dysphagia (n = 4) and dysphonia (n = 1); postsurgical neurological worsening in three cases (two improved and one remained grade 4); vertebral artery injury in one case; and an urgent evacuation of a prevertebral hematoma. One patient died due to respiratory disturbances. Cervical corpectomy is efficient for spinal cord decompression, especially when anterior components (disk osteophyte, OPLL...) bulge in the spinal cord. A three or more level corpectomy was not considered in this series since they may be associated to high rate morbidity. We found that this decompression led to better clinical results in patient grades 0 and 1 and to poorer results as myelopathy progressed. Among complications, subsidence was the most frequent specific one, but since it was rarely associated with symptoms, the majority of patients were successfully treated conservatively.


  • A prospective study of a series of 356 patients with supratentorial spontaneous intracerebral haematomas treated in a Neurosurgical Department

    by G. Bilbao, J. Garibi, I. Pomposo, J. I. Pijoan, A. Carrasco, G. Catalán, S. González

    Background. Spontaneous supratentorial intracerebral haemorrhages (SSIH) carry high morbidity and mortality rates. At present, the proper role of surgery is not clear and data from the International STICH trial have not clarified this challenging question. On the other hand, few prospective studies have measured long term survival regardless of the treatment and clinical condition of the patient. Patients and methods. We prospectively collected data from all SSIH patients (n = 356) admitted at a tertiary reference hospital over a 40-month time period regardless of their clinical condition and treatment received. Among data investigated were preclinical neurological state, GCS on admission, history of systemic hypertension and treatment (surgical or conservative). Clinical factors influencing mortality at 1-year follow-up were analysed statistically by univariable and multivariable methods. Findings. We found that patients in the eighth decade were the most frequent. Hypertension was present in 47% of patients. Based on the prehospitalisation modified Rankin Scale, 305 (86%) patients were independent for activities of daily living (ADL). At 12-months follow-up, 91 (46% of alive patients) remained independent for ADL. The surgical rate was 22%. Although it was not a randomised study, we did not find a significantly different mortality rate according to whether the patient was treated surgically or conservatively. Overall, the mortality rate was 44% (157 patients) with a 79% of deaths taking place in the first 30 days after admission. Conclusions. This study underscores the high mortality rate of SSIH, especially so in the first month after admission. Among the subgroup of patients clinically independent before the haemorrhagic stroke, only 29.8% remained independent one year after the event. We did not find any statistically significant difference in mortality according to treatment modality received (surgical vs conservative) although treatment assignment was not randomised. Among other clinical factors, pre-ictal functional status, age, level of consciousness on admission and volume of haemorrhage strongly influence mortality as determined at the 1-year follow-up.